The Future of Personalised Medicine for Cancer 

Understand the rise of ‘omics’  – genomics and epigenomics – with leading experts exploring cutting edge treatments and interventions in the quest for more personalised cancer medicine.


Personalised medicine – is this the future for cancer treatment?

Professor Simon Leedham, Centre for Personalised Medicine, Wellcome Trust Centre for Human Genetics, Oxford


The 100,000 Genomes Project – a key aim is to improve cancer care in NHS

Mark Caulfield, Chief Scientist, Genomics England


The Oncotype DX test – a case study

Nigel Bundred, Professor of Surgical Oncology, University Hospital of South Manchester NHS Trust


Patients’ perspective on genomics in cancer

Jayne Spink, Chief Executive, Genetic Alliance UK Genetic Alliance supports and campaigns for people with genetic conditions and patients whose healthcare and treatment is affected by their genetic profile.


Chair Dr Martin Scurr

Former GP, Hospice director, medical consultant and journalist


Genomic logo





‘The Guild of Health Writers thanks Genomic Health for their generous sponsorship of this event and would like to state that this is an independent event. In accordance with its objectives, the Guild aims to provide a balanced, non-partisan forum for discussion and does not endorse any commercial products’.

Tickets: £10 Guild members, £15 non-member guests (invited by Guild members)

For tickets please contact the Guild office –